home.social

#abbvie — Public Fediverse posts

Live and recent posts from across the Fediverse tagged #abbvie, aggregated by home.social.

  1. Korea @[email protected] ·

    SK Biopharmaceuticals Recruits Novartis Veteran Kim Tae-ho to Lead New Neuroscience R&D Division — BigGo Finance

    SK Biopharmaceuticals (326030) is strengthening its full-cycle R&D capabilities—spanning candidate discovery, clinical development, and commercialization—through a series of…
    #EuropeSays #Korea #KR #SK #AbbVie #BristolMyersSquibb #KimSoo-young #KimTae-ho #LeeDong-hoon #Novartis #RyanKruger #SKBiopharmaceuticals #SKGroup #SKLifeScienceLabs #SunitaMisra #Xcopri
    europesays.com/korea/146781/

    #xcopri #sunitamisra #sklifesciencelabs #skgroup #skbiopharmaceuticals #ryankruger
  2. Switzerland @[email protected] ·

    europesays.com/ch/127341/ SK Biopharmaceuticals Recruits Novartis Veteran Kim Tae-ho to Lead New Neuroscience R&D Division — BigGo Finance #AbbVie #BristolMyersSquibb #KimSooYoung #KimTaeHo #LeeDongHoon #Novartis #RyanKruger #SKBiopharmaceuticals #SKLifeScienceLabs #SunitaMisra #Xcopri

    #xcopri #sunitamisra #sklifesciencelabs #skbiopharmaceuticals #ryankruger #novartis
  3. UK @[email protected] ·

    europesays.com/uk/1095559/ AbbVie (ABBV) Wins EU Approval For Boey Frown Line Treatment In Europe #AbbVie #AllerganAesthetics #boey #EU #Europe #European #EuropeanAesthetics #SimplyWallSt #TreatmentDuration

    #treatmentduration #simplywallst #europeanaesthetics #european #europe #eu
  4. cafepharma @[email protected] ·

    5 neuro data readouts to watch in the second half of 2024 — GSK moves to new HQ in return to central London — AbbVie led the way in paying doctors to pitch its drugs last year —bit.ly/w28kSd #clinicaltrials #neurology #gsk #london #abbvie #physicians #physicianpayments #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

    #clinicaltrials #neurology #gsk #london #abbvie #physicians
  5. cafepharma @[email protected] ·

    AbbVie's tight grip on Humira market raises concerns about biosimilars—As biotech recovers, venture firms’ preferences appear to shift — Boehringer, Zealand heat up MASH race with strong phase II data—bit.ly/w28kSd #abbvie #humira #biosimilars #funding #mash #nash #boehringeringelheim #ipos #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

    #abbvie #humira #biosimilars #funding #mash #nash
  6. cafepharma @[email protected] ·

    AbbVie trumpets Skyrizi's resounding win against J&J's Stelara in Crohn's disease -- Novo Nordisk buys rival to Bayer's kidney drug Kerendia in $1.3B deal -- AZ’s Tagrisso plus chemo get fast FDA review for lung cancer -- See more on our front page news bit.ly/w28kSd #novonordisk #bayer #kidneydisease #astrazeneca #fda #lungcancer #crohns #abbvie #jnj #skyrizi #stelara #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

    #novonordisk #bayer #kidneydisease #astrazeneca #fda #lungcancer